Accentuating the Positive: Do Trials Give Unrealistic Expectations of Long-Term Survival?

od Kiely, Belinda E, Stockler, Martin R
Wydane w JNCI Cancer Spectr (2019)

When Should Oncologists Use the Words Hope and Cure?

od Kiely, Belinda E, Stockler, Martin R
Wydane w JNCI Cancer Spectr (2020)

Clinical research during coronavirus disease pandemic: Challenges and way forward

od Panda, Pankaj Kumar, Stockler, Martin R, Gulia, Ashish
Wydane w Indian J Med Sci (2020)

Duration of chemotherapy for metastatic breast cancer

od Stockler, Martin R, Wilcken, Nicholas, Coates, Alan, Ghersi, Davina
Wydane w Cochrane Database Syst Rev (2018)

Discussing and prescribing expensive unfunded anticancer drugs in Australia

od Karikios, Deme John, Mileshkin, Linda, Martin, Andrew, Ferraro, Danielle, Stockler, Martin R
Wydane w ESMO Open (2017)

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

od Mercieca-Bebber, Rebecca, King, Madeleine T, Calvert, Melanie J, Stockler, Martin R, Friedlander, Michael
Wydane w Patient Relat Outcome Meas (2018)

Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer

od Lawrence, Nicola Jane, Roncolato, Felicia, Martin, Andrew, Simes, Robert John, Stockler, Martin R
Wydane w JNCI Cancer Spectr (2018)

Societal perspective on access to publicly subsidised medicines: A cross sectional survey of 3080 adults in Australia

od Chim, Lesley, Salkeld, Glenn, Kelly, Patrick, Lipworth, Wendy, Hughes, Dyfrig A., Stockler, Martin R.
Wydane w PLoS One (2017)

Patient-Reported Outcomes Associated with Treatments for Testicular Cancer: A Systematic Review

od Mercieca-Bebber, Rebecca, Naher, Sayeda Kamrun, Rincones, Orlando, Smith, Allan Ben, Stockler, Martin R
Wydane w Patient Relat Outcome Meas (2021)

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review

od Mercieca-Bebber, Rebecca, Palmer, Michael J, Brundage, Michael, Calvert, Melanie, Stockler, Martin R, King, Madeleine T
Wydane w BMJ Open (2016)

Bisphosphonates and other bone agents for breast cancer

od O'Carrigan, Brent, Wong, Matthew HF, Willson, Melina L, Stockler, Martin R, Pavlakis, Nick, Goodwin, Annabel
Wydane w Cochrane Database Syst Rev (2017)

Need for Global Partnership in Cancer Care: Perceptions of Cancer Care Researchers Attending the 2010 Australia and Asia Pacific Clinical Oncology Research Development Workshop

od Lyerly, H. Kim, Abernethy, Amy P., Stockler, Martin R., Koczwara, Bogda, Aziz, Zeba, Nair, Reena, Seymour, Lesley
Wydane 2011

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

od Lin, Hui-Ming, Mahon, Kate L, Spielman, Calan, Gurney, Howard, Mallesara, Girish, Stockler, Martin R, Bastick, Patricia, Briscoe, Karen, Marx, Gavin, Swarbrick, Alexander, Horvath, Lisa G
Wydane w Br J Cancer (2017)

Patients’ Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer

od Blinman, Prunella, Martin, Andrew, Jefford, Michael, Goldstein, David, Boadle, David, Morris, Michelle, Tebbutt, Niall, Aiken, Christine, Harkin, Andrea, Segelov, Eva, Haydon, Andrew, Iveson, Tim, Stockler, Martin R
Wydane w JNCI Cancer Spectr (2020)

Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom...

od Sjoquist, Katrin M., Friedlander, Michael L., O'Connell, Rachel L., Voysey, Merryn, King, Madeleine T., Stockler, Martin R., Oza, Amit M., Gillies, Kim, Martyn, Julie K., Butow, Phyllis N.
Wydane 2013

Regional Variation in Identified Cancer Care Needs of Early-Career Oncologists in China, India, and Pakistan

od Lyerly, H. Kim, Fawzy, Maria R., Aziz, Zeba, Nair, Reena, Pramesh, C.S., Parmar, Vani, Parikh, Purvish M., Jamal, Rozmin, Irumnaz, Azizunissa, Ren, Jun, Stockler, Martin R., Abernethy, Amy P.
Wydane w Oncologist (2015)

Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

od Blinman, Prunella, Mileshkin, Linda, Khaw, Pearly, Goss, Geraldine, Johnson, Carol, Capp, Anne, Brooks, Susan, Wain, Gerard, Kolodziej, Ilka, Veillard, Anne-Sophie, O'Connell, Rachel, Creutzberg, Carien L, Stockler, Martin R
Wydane w Br J Cancer (2016)

The role of mindfulness in distress and quality of life for men with advanced prostate cancer

od Chambers, Suzanne K., Foley, Elizabeth, Clutton, Samantha, McDowall, Robert, Occhipinti, Stefano, Berry, Martin, Stockler, Martin R., Lepore, Stephen J., Frydenberg, Mark, Gardiner, Robert A., Davis, Ian D., Smith, David P.
Wydane w Qual Life Res (2016)

What Survival Benefits are Needed to Make Adjuvant Sorafenib Worthwhile After Resection of Intermediate- or High-Risk Renal Cell Carcinoma? Clinical Investigators’ Preferences in t...

od Lawrence, Nicola J., Martin, Andrew, Davis, Ian D., Troon, Simon, Sengupta, Shomik, Hovey, Elizabeth, Coskinas, Xanthi, Kaplan, Richard, Smith, Benjamin, Ritchie, Alastair, Meade, Angela, Eisen, Tim, Blinman, Prunella, Stockler, Martin R.
Wydane w Kidney Cancer (2018)

A randomised controlled trial of an advance care planning intervention for patients with incurable cancer

od Johnson, Stephanie B., Butow, Phyllis N., Bell, Melanie L., Detering, Karen, Clayton, Josephine M., Silvester, William, Kiely, Belinda E., Clarke, Stephen, Vaccaro, Lisa, Stockler, Martin R., Beale, Phillip, Fitzgerald, Natalie, Tattersall, Martin H. N.
Wydane w Br J Cancer (2018)